Guru Ownership Trend
Guru Analysis for ImmunityBio, Inc. (IBRX)
ImmunityBio, Inc. (IBRX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $6.87 M.
Top institutional holders include Paul Tudor Jones and Jefferies Group.
Institutional sentiment is currently Bullish. This is evidenced by a $4.5 M net inflow during the quarter.
Recent activity highlights Paul Tudor Jones who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for ImmunityBio, Inc. (IBRX)
Major holders include Paul Tudor Jones ($4.4 M), Jefferies Group ($2.3 M), Cliff Asness ($510,415). According to the latest reported data, 4 tracked investment managers collectively hold approximately 951,705 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $4.5 M, with 4 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited IBRX. The total reported sell value was $2.44 M.
Yes, 3 managers opened new positions in IBRX, and 1 increased their existing holdings. The total reported buy value was $6.94 M.